Gargoyle Investment Advisor’s Elevance Health ELV Stock Holding History

Gargoyle Investment Advisor’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-7,052	Closed	-$1.85M	–	120
2018 Q4	$1.85M	Hold	7,052	–	–	1.69%	16
2018 Q3	$1.93M	Sell	7,052 -1,434	-17%	-$372K	1.39%	34
2018 Q2	$2.02M	Hold	8,486	–	–	1.12%	45
2018 Q1	$1.86M	Sell	8,486 -5,514	-39%	-$1.3M	0.77%	58
2017 Q4	$3.15M	Hold	14,000	–	–	1.25%	24
2017 Q3	$2.66M	Sell	14,000 -4,000	-22%	-$761K	0.98%	39
2017 Q2	$3.39M	Hold	18,000	–	–	1.34%	12
2017 Q1	$2.98M	Hold	18,000	–	–	1.15%	21
2016 Q4	$2.59M	Hold	18,000	–	–	1.01%	39
2016 Q3	$2.26M	Hold	18,000	–	–	0.85%	59
2016 Q2	$2.36M	Buy	+18,000	New	+$2.46M	0.88%	46

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Gargoyle Investment Advisor's ELV Position: Q1 2019 in Review

Gargoyle Investment Advisor sold out of Elevance Health (ELV) in Q1 2019, closing a stake of 7,052 shares — an estimated $1.85M sold.

Gargoyle Investment Advisor first reported a position in ELV in Q2 2016 and held it in 11 quarters. The position peaked at $3.39M in Q2 2017. 1,074 funds tracked by Wall St. Rank hold ELV as of Q1 2019.

Gargoyle Investment Advisor reported no remaining Elevance Health position as of Q1 2019 after selling out during the quarter.
Gargoyle Investment Advisor sold 7,052 Elevance Health shares in Q1 2019, an estimated $1.85M.
Gargoyle Investment Advisor first reported a position in Elevance Health in Q2 2016 and held it in 11 quarters.
Gargoyle Investment Advisor's Elevance Health position peaked at $3.39M in Q2 2017.
1,074 funds tracked by Wall St. Rank held Elevance Health as of Q1 2019.

Based on Gargoyle Investment Advisor's 13F filing for Q1 2019, filed 14 May 2019.